March 23, 2020 / 8:24 PM / in 10 days

BRIEF-Axcella Health Q4 Loss Per Share $0.68

Axcella Health Inc:

* AXCELLA REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q4 LOSS PER SHARE $0.68

* Q4 EARNINGS PER SHARE ESTIMATE $-0.74 — REFINITIV IBES DATA

* AXCELLA HEALTH - ON TRACK TO REPORT TOP-LINE DATA FOR LEAD CANDIDATES FOR NONALCOHOLIC STEATOHEPATITIS, OVERT HEPATIC ENCEPHALOPATHY IN MID-2020

* AXCELLA HEALTH - CASH AND CASH EQUIVALENTS AT DEC 31, 2019 WERE $92.1 MILLION, WHICH COMPARES WITH $79.5 MILLION AT DEC 31, 2018

* AXCELLA HEALTH - ENROLLMENT AND DOSING IN AXA1957 PEDIATRIC CLINICAL STUDY HAS BEEN TEMPORARILY SUSPENDED

* CONTINUES TO VIEW PEDIATRIC NASH AS A SIGNIFICANT AREA OF UNMET NEED

* EXPECTS CASH, EQUIVALENTS WILL BE SUFFICIENT TO MEET OPERATING NEEDS INTO Q2 OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below